TNF and rheumatoid arthritis: At present, the western drugs for RA can be divided into five generations according to the development time and principles: nonsteroidal anti-inflammatory drugs, glucocorticoids, disease-modifying antirheumatic drugs, early biological agents mainly composed of TNF-α inhibitors, and new biological agents directly targeting T cells.